Analyst Ratings for Allscripts Healthcare Solutions Inc. (MDRX)Updated: 2017-07-26
Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, MDRX was issued an average rating of Overweight.
9 analysts declared MDRX a buy, 2 gave an overweight rating, 14 issued a hold rating, 0 issued an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
Several price targets were given for MDRX by the analysts covering the stock. The most optimistic price target was 17, which equates to a potential upside of 35.89 percent. The most pessimistic price target was 11, implying potential capital losses of -12.07 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 0 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.26 percent.
People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.
MDRX has a 52-week high of 15.17 and a 52-week low of 9.80. Today's price is 27.65 percent above the 52-week low, and below the high by 17.53 percent. MDRX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDRX value stock report compares MDRX to some of its peers using value stock charts. The market cap of MDRX is $2.25 billion. MDRX is estimated to release their earnings results for the quarter on 0000-00-00, days from today.